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Introduction
•

•

•

Lynch syndrome (LS) runs in
families as an autosomal
dominant disease. This means
that if one parent carries a
mutated Lynch syndrome gene,
there is a 50 percent chance
that the mutation will be
passed on to each child. (8)
This topic was chosen because
I have Lynch Syndrome .
Lynch syndrome previously
known as Hereditary Nonpolyposis colorectal cancer
syndrome (HNPCC) (9).
Lynch syndrome the
preponderance of an innate
cancer syndrome, the most
common cause of heritable
colorectal cancer, and the only
known heritable cause of
endometrial cancer. Lynch
syndrome is associated with
cancers of the ovary, stomach,
urothelial tract, small bowel,
less frequently, cancers of the
brain (glioblastoma), biliary
tract, pancreas, and prostate
(3).
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U.S. National Library of Medicine, 2013.

Pathophysiological Process

Significance of Pathophysiology

Underlying Pathophysiology
Lynch Syndrome is confirmed by a mutation in one
of several mismatch repair (MMR) genes.(10)
DNA is the genetic material that embodies
instructions for every chemical process in the body.
As cells grow and divide, DNA is copied, and it is
common for minor mistakes to occur. (8)
MMR normally responsible for correcting mistakes
in the deoxyribonucleic acid (DNA) sequence. (8)
MMR genes include MLH1, MSH2, MSH6, PMS2
or by a mutation in the EPCAM gene. (10)
EPCAM gene is not involved in DNA repair (2)
The EPCAM gene has been shown to cause Lynch
Syndrome by turning off its neighboring MSH2
gene (2)
The errors preferentially accumulate in regions of
the genome called microsatellites.
Microsatellites are areas where repeating of DNA
sequences, in which one to a few nucleotides (e.g.,
adenine-, cytosine-, guanine-, or thymine-based
DNA elements) are repeated”(3) The linear
sequence of DNA is symbolized by the first letter
of the nucleotide base. When describing
nucleotides, the first letter is used for
identification, adenine (A), cytosine (C), guanine
(G), thymine (T). (3)
Normal cells have mechanisms to recognize these
mistakes and repair them.(8) but during DNA
synthesis, mutations can occur in microsatellites
causing misalignments of the repetitive
sequences. (3)
However, people who inherit a mutated version of
one of the genes associated with Lynch syndrome
cannot repair these minor mistakes leading to
permanent changes or mutations in the DNA
sequences (8)
An accumulation of such misalignments can lead
to the cells becoming cancerous. (8)

United States, approximately has 140,000 new cases
of colorectal cancer are diagnosed each year. About
three to five percent of these cancers are caused by
Lynch syndrome (U.S. National Library of Medicine,
2013). The significance of understanding genetics
and genetic mutations and individual risk factors is
imperative to preventative treatment and early
detection

Implications for Nursing Care
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Sign & Symptoms
•

The median age for diagnosis for Lynch Syndrome is between 44 and 61 in
contrast to 66 years of age in sporadic cases of Colorectal Cancer (CRC)
(Harrison & Handley, 2017).
Signs of LS include a genetic predisposition to many primary cancers in the same
person or on one side of the family; these cancers may be the same or different
types of cancers known to be genetically linked. (Pasalodos-Sanchez, Howard, &
Scotting, 2013).
Identification may also include some rare cancers clustered in a family, diagnosis
younger than average age, a particular genetic ancestry (Pasalodos-Sanchez et al.,
2013) Understanding the family tree or family pedigree for determining carrier of
mutated genes.
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Top symptoms
80-99% Have the following
Abdominal pain
Colon cancer
Constipation,
Fatigue
Gastrointestinal hemorrhage,
Glioblastoma multiforme
Malabsorption,
Weight loss.
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30-79%
Anxiety
Attention deficit hyperactivity disorder
(ADHD)
death in early adulthood
death in infancy depression
Hypertonia
Increased intracranial pressure
Irritability
Migraine
Muscular hypotonia, Nausea and
vomiting
Neoplasm of the rectum
Seizures
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Conclusion
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Lynch Syndrome is a genetic mutation that can lead to
cancer. Identification and preventive screening is key to
surviving and thriving with LS.
Below is the recommendation for individuals with LS.
Completing genetic family history screening (GFHS)
questionnaires during initial family history survey (4).
Utilizing the GFHS questionnaire supports the identification of atrisk individuals for Lynch Syndrome who would benefit from
genetic evaluation and testing (4)
Serum (blood) Germline sequencing of the MMR genes remains
the gold standard for confirming the causative gene mutation for
Lynch Syndrome (5)
The questionnaire encompasses multiple testing and diagnostic
criteria from Original Amsterdam Criteria, Revised Amsterdam
Criteria(Amsterdam Criteria II), Original Bethesda Criteria,
Revised Bethesda Guidelines (1)
People diagnosed with LS will need preventive screening and
surgical procedures to reduce the incidence of a cancer diagnosis.
Addition screening and testing will need to be ordered for these
patients including having a family discussion and being sent for
their genetic counseling and potential testing.
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Variable associated with LS

Recommendation

Screening/Testing



Colonoscopy

Annually or biennial

Starting at age 20-25 years or 2 –
5 years before earliest CRC
diagnosis in the family



Endometrial cancer

Annually



Ovarian cancer

Annually



Prophylactic hysterectomy
and oophorectomy

Recommendation



Gastric cancer

Consideration for at risk

Pelvic exam, endometrial
sampling starting 30-35 years
Transvaginal ultrasound starting
age 30-35 years
Hysterectomy and bilateral
salpingo-oophorectomy who have
finished childbearing or 40 years
Esoghagogastroduodenoscopy
with gastric biopsy of antrum at
30-35 years



Small Intestinal cancer



No routine screening
recommended at this time
Annually



Cancers of the urinary
tract
Pancreatic cancer



Breast and prostate cancer



Treatment/Prevention

No routine screening
recommended at this time
No special recommendations for
LS
Colectomy and Aspirin

Urinalysis starting at 30-35 years

Routine general population
screening
Colectomy with ileorectal
anastomosis primary treatment
for colon cancer or colon
neoplasia not removable by
endoscopy. Aspirin treatment is
growing but is not conclusive.
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